PFE - Inovio: A Viable Short Falling Behind The Leaders In COVID-19 Vaccine Development
When COVID-19 reared its head, of course vaccine-maker Inovio Pharmaceuticals (INO) threw its hat into the ring, like it does with each epidemic or pandemic. Is this time going to be different to the last? Or is INO stock set to continue fading.
Data by YCharts
Figure 1: Year-to-date trading of INO. Source: YCharts.
INO-4800
INO-4800 is a DNA vaccine, which comes with substantial advantages. The vaccine is very stable compared to some other vaccines, it doesn't require frozen storage or transport. DNA vaccines can be designed and produced quickly too. INO took